Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an <i>In Vivo</i> Anti-CD19 CAR T Cell Therapy
Alissa Brandes(Unknown), Ryan Larson(CTI BioPharma (United States)), Anai M. Perez(Fred Hutch Cancer Center), Jeffrey Teoh, Sarah Dickerson, Byoung Y. Ryu(CTI BioPharma (United States)), Alyssa Sheih(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sarah Gould(Array BioPharma (United States)), Travis J. Friesen, Andrew M. Scharenberg(CTI BioPharma (Italy)), Nolan G. Ericson, Kathryn Michels(CTI BioPharma (United States)), Susana Hernández, Alessandra M. Sullivan(CTI BioPharma (United States)), A. Koo, Mason Muhonen(Array BioPharma (United States)), Don Parilla, Jessica Freeman(Array BioPharma (United States))
Cited by 5
Related Papers
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897
TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization
|Cell|2002|751
A Unified Nomenclature for the Superfamily of TRP Cation Channels
|Molecular Cell|2002|679